The ASX 200 Health Care Index fell 4.83% in October and is now deep in red territory for 2025 as heavy CSL fall weighs on ...

Mont Royal Resources has returned to the boards in strong fashion after completing a merger and securing a Canadian REE ...

The ASX drifted lower by lunchtime as miners and tech fell again. Meanwhile, Michael Burry has resurfaced, with fresh shorts ...

CSL has used the first session of its capital markets fiesta in Chicago to assure investors the company has a flu vaccine ...

Tryptamine Therapeutics (ASX:TYP) raises $6.1 million to advance its clinical trial for TRP-8803 for treating binge eating ...

Older Australians who stop working but fail to inform their super funds of their retirement are paying 15 per cent tax on their super.

Race Oncology, EZZ Life Science and Neurotech International are among ASX health companies reporting quarterly results.

October was rough for Aussie tech, with Xero and WiseTech dragging the XIJ down 8pc, but behind the red ink a new crop of ...

Amid a slew of secondary equity raisings and at least two planned IPOs, the biotech sector is ending a difficult year on a ...

The executive team behind De Grey Mining has resurfaced, powering gains at the Richardson Street Group's Bellavista Resources ...

Lithium may have turned a corner in October, while gold and copper both touched record highs before late pullbacks.

The ASX 200 has reset to levels seen over a month ago, falling on broad weakness across sectors as the RBA remains hawkish on ...